Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Ekso Bionics Holdings, Inc.

Ekso Bionics Holdings, Inc. (EKSO) Stock Overview

Explore Ekso Bionics Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

EKSO●NASDAQ
HealthcareMedical - Equipment & Services
$15.90
$1.74(9.86%)
U.S. Market opens in 53h 28m

Ekso Bionics Holdings, Inc. (EKSO)

Meyka AI Score

Z

Key Financials

Market Cap38.6M
P/E Ratio-2.95
EPS (TTM)$-5.11
ROE-1.77%
Fundamental Analysis

AI Price Forecasts

1 Month$22.11
3 Months$25.47
1 Year Target$20.49

EKSO Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Ekso Bionics Holdings, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of EKSO on the NASDAQ shows an RSI of 52.51, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $20.49 for the NASDAQ listing.

Key metrics behind Ekso Bionics Holdings, Inc.'s NASDAQ-traded stock include a P/E ratio of -2.95 and a market capitalization of 38.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of EKSO on the NASDAQ.

Price Performance (NASDAQ: EKSO)

1-Day Change
N/A
5-Day Change
-26.52%
1-Month Change
-9.86%
3-Month Change
34.86%
6-Month Change
82.76%
Year-to-Date (YTD) Change
84.03%
1-Year Change
355.59%
3-Year Change
-4.50%
5-Year Change
-78.54%
All-Time (Max) Change
-99.57%

Contact Information

http://www.eksobionics.com
510 984 1761
101 Glacier Point, San Rafael, CA, 94901

Company Facts

530 Employees
IPO DateJan 15, 2014
CountryUS

Frequently Asked Questions